ALG5
protein-codingALG5 dolichyl-phosphate beta-glucosyltransferase, the group of Glycosyltransferase family 2
Gene summary
This gene encodes a member of the glycosyltransferase 2 family. The encoded protein participates in glucosylation of the oligomannose core in N-linked glycosylation of proteins. The addition of glucose residues to the oligomannose core is necessary to ensure substrate recognition, and therefore, effectual transfer of the oligomannose core to the nascent glycoproteins. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~51.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0031062
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0031062
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0031062
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0031062
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0004691
Submitter: ClinGen
*ALG5* is located at chromosome 13q13.3 and encodes dolichyl phosphate glucosyltransferase, an transmembrane-bound enzyme of the endoplasmic reticulum that is involved in protein N-linked glycosylation via catalyzing the transfer of glucose from UDP glucose to dolichyl phosphate (PMID: 8076653). *ALG5* was first reported in relation to autosomal dominant polycystic kidney disease(ADPKD) in 2022 (Lemoine H et al., 2022 PMID: 35896117). Common phenotypes for individuals *ALG5* variants and ADPKD include late-onset development of CKD, atrophic kidneys, and multiple millimeter-sized kidney cysts (PMID: 35896117). Five unique variants (1 frameshift, 1 deletion, 1 nonsense, 2 missense) reported in five probands in one publication (PMID: 35896117) were included in this curation. The mechanism of pathogenicity is known to be loss-of-function. A total of 7.1 genetic evidence points was reached, considering case-level and segregation data. This gene-disease relationship is also supported by biochemical functional assay demonstrating that disruption of *ALG5*-mediated N-linked protein glycosylation leads to impaired maturation of polycystin 1 (PC1); impaired maturation of PC1 is implicated in the pathogenesis of cyst formation and polycystic kidney disease (PMID: 30523303). A total number of 0.5 experimental evidence points was reached. In summary, there is moderate evidence supporting the relationship between *ALG5* and ADPKD. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Kidney Cystic and Ciliopathy Disorders GCEP on the meeting date 03/22/2023 (SOP version 9).
Clinical Genomic Database (CGD)
Manifestation: Gastrointestinal; Renal
Intervention: Renal
Rationale: Treatment for hypertension and end-stage renal disease is frequently required, and nephrotoxic agents should be avoided
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ALG5 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_013338.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 4 | 2 | 8 | ||
| missense | 3 | 47 | 8 | 58 | ||
| nonsense | 3 | 2 | 2 | 7 | ||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 6 | 7 | |||
| Total | 7 | 3 | 57 | 12 | 2 | 81 |
Highest pathogenic variant AF is 0.0000037312875
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_037470.1 | 10 | MANE Select | |
| Ensembl | ENSP00000239891.3 | 10 | MANE Select | |
| RefSeq | NP_001135836.1 | 9 | Standard | |
| Ensembl | ENSP00000390533.1 | 9 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- N-Glycan biosynthesis - Homo sapiens (human)
- Post-translational protein modification
- Metabolism of proteins
- dolichyl-diphosphooligosaccharide biosynthesis
- Synthesis of dolichyl-phosphate-glucose
Biological Process
- protein glycosylation
- protein N-linked glycosylation
- determination of left/right symmetry
- protein N-linked glycosylation via asparagine
Molecular Function
- oligosaccharyl transferase activity
- dolichyl-phosphate beta-glucosyltransferase activity
Cellular Component
- endoplasmic reticulum membrane
- membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000239891
- Coding exons
- 10
- Length
- 50487
- Individuals with no LoFs
- 125737
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 11
- Defined
- 125748
- p
- 0.0000437
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.01 | 143 | 181 | 0.790 | 0.0000100 | 2087 |
| Missense (PolyPhen) | 31 | 59.827 | 0.51816 | 634 | ||
| Synonymous | -0.279 | 65 | 62.2 | 1.04 | 0.00000321 | 628 |
| Loss of Function | 3.50 | 5 | 23.2 | 0.215 | 0.00000145 | 238 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000087 | 0.000087 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000048 | 0.000044 | rare |
| South Asian | 0.000074 | 0.000065 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.150
Intolerance Scores
- LoFtool
- 0.551
- RVIS EVS
- 0.08
- RVIS percentile EVS
- 60.09
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.949
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |